Found: 166
Select item for more details and to access through your institution.
Recombinant factor VIIa for unlicensed indications--a definite No or a cautious Maybe in selected patients?
- Published in:
- 2010
- By:
- Publication type:
- editorial
An Integrated Strategy for Evaluation of Metabolic and Oxidative Defects in Neurodegenerative Illness Using Magnetic Resonance Techniques.
- Published in:
- Annals of the New York Academy of Sciences, 1999, v. 893, n. 1, p. 214, doi. 10.1111/j.1749-6632.1999.tb07828.x
- By:
- Publication type:
- Article
Teicoplanin administration in patients experiencing reactions to vancomycin.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Recombinant factor VIIa for unlicensed indications - a definite No or a cautious Maybe in selected patients?
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Can Internet surveys help us understanding allergic disorders? - results from a large survey in urticaria in Greece.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2011, v. 25, n. 5, p. 532, doi. 10.1111/j.1468-3083.2010.03817.x
- By:
- Publication type:
- Article
Treatment of nail psoriasis with adalimumab: an open label unblinded study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2010, v. 24, n. 5, p. 530, doi. 10.1111/j.1468-3083.2009.03453.x
- By:
- Publication type:
- Article
Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2008, v. 22, n. 12, p. 1405, doi. 10.1111/j.1468-3083.2008.02840.x
- By:
- Publication type:
- Article
Combined metabolome and transcriptome profiling provides new insights into diterpene biosynthesis in S. pomifera glandular trichomes.
- Published in:
- BMC Genomics, 2015, v. 16, p. 1, doi. 10.1186/s12864-015-2147-3
- By:
- Publication type:
- Article
Use of the de novo transcriptome analysis of silver-leaf nightshade (Solanum elaeagnifolium) to identify gene expression changes associated with wounding and terpene biosynthesis.
- Published in:
- BMC Genomics, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12864-015-1738-3
- By:
- Publication type:
- Article
Use of the de novo transcriptome analysis of silver-leaf nightshade (Solanum elaeagnifolium) to identify gene expression changes associated with wounding and terpene biosynthesis.
- Published in:
- BMC Genomics, 2015, v. 16, n. 1, p. 504, doi. 10.1186/s12864-015-1738-3
- By:
- Publication type:
- Article
Safety surveillance in haemophilia and allied disorders.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Recurrent miscarriage: aetiology, management and prognosis.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Isoprenoid biosynthesis in the diatom Haslea ostrearia.
- Published in:
- New Phytologist, 2019, v. 222, n. 1, p. 230, doi. 10.1111/nph.15586
- By:
- Publication type:
- Article
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.
- Published in:
- Haemophilia, 2018, v. 24, n. 3, p. 344, doi. 10.1111/hae.13495
- By:
- Publication type:
- Article
A golden age for Haemophilia treatment?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. 104, doi. 10.1111/hae.13324
- By:
- Publication type:
- Article
Haemophilia of the third age.
- Published in:
- Haemophilia, 2018, v. 24, n. 1, p. 15, doi. 10.1111/hae.13257
- By:
- Publication type:
- Article
The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.
- Published in:
- Haemophilia, 2017, v. 23, n. 5, p. e469, doi. 10.1111/hae.13290
- By:
- Publication type:
- Article
First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties.
- Published in:
- Haemophilia, 2017, v. 23, n. 5, p. 654, doi. 10.1111/hae.13264
- By:
- Publication type:
- Article
von Willebrand disease and extra-intestinal angiodysplasia.
- Published in:
- Haemophilia, 2017, v. 23, n. 4, p. e354, doi. 10.1111/hae.13204
- By:
- Publication type:
- Article
SIPPET trial: the answers.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series.
- Published in:
- Haemophilia, 2017, v. 23, n. 2, p. 255, doi. 10.1111/hae.13167
- By:
- Publication type:
- Article
Hepatitis C in haemophilia: time for treatment for all.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
New Findings on Inhibitor Development: from Registries to Clinical Studies.
- Published in:
- Haemophilia, 2017, v. 23, p. 4, doi. 10.1111/hae.13137
- By:
- Publication type:
- Article
Inhibitor development in haemophilia.
- Published in:
- Haemophilia, 2017, v. 23, p. 3, doi. 10.1111/hae.13145
- By:
- Publication type:
- Article
Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
- Published in:
- Haemophilia, 2016, v. 22, n. 5, p. 806, doi. 10.1111/hae.12962
- By:
- Publication type:
- Article
Care models in the management of haemophilia: a systematic review.
- Published in:
- Haemophilia, 2016, v. 22, p. 31, doi. 10.1111/hae.13000
- By:
- Publication type:
- Article
NHF-McMaster Guideline on Care Models for Haemophilia Management.
- Published in:
- Haemophilia, 2016, v. 22, p. 6, doi. 10.1111/hae.13008
- By:
- Publication type:
- Article
Congenital macrothrombocytopenia is a heterogeneous disorder in India.
- Published in:
- Haemophilia, 2016, v. 22, n. 4, p. 570, doi. 10.1111/hae.12917
- By:
- Publication type:
- Article
Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.
- Published in:
- Haemophilia, 2016, v. 22, n. 2, p. 179, doi. 10.1111/hae.12805
- By:
- Publication type:
- Article
Von Willebrand factor activity assay errors.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. e74, doi. 10.1111/hae.12862
- By:
- Publication type:
- Article
FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. e36, doi. 10.1111/hae.12764
- By:
- Publication type:
- Article
The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease.
- Published in:
- Haemophilia, 2015, v. 21, n. 3, p. 338, doi. 10.1111/hae.12571
- By:
- Publication type:
- Article
FXI concentrate use and risk of thrombosis.
- Published in:
- Haemophilia, 2014, v. 20, n. 4, p. e349, doi. 10.1111/hae.12457
- By:
- Publication type:
- Article
Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen.
- Published in:
- Haemophilia, 2014, v. 20, n. 4, p. 587, doi. 10.1111/hae.12365
- By:
- Publication type:
- Article
Enhancing haemophilia care through registries.
- Published in:
- Haemophilia, 2014, v. 20, p. 121, doi. 10.1111/hae.12406
- By:
- Publication type:
- Article
Enhancing haemophilia care through registries.
- Published in:
- Haemophilia, 2014, v. 20, p. 121, doi. 10.1111/hae.12406
- By:
- Publication type:
- Article
Assaying FVIII activity: one method is not enough, and never was.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity.
- Published in:
- Haemophilia, 2014, v. 20, n. 2, p. 200, doi. 10.1111/hae.12283
- By:
- Publication type:
- Article
Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand disease.
- Published in:
- Haemophilia, 2013, v. 19, n. 3, p. e191, doi. 10.1111/hae.12139
- By:
- Publication type:
- Article
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.
- Published in:
- Haemophilia, 2013, v. 19, p. 1, doi. 10.1111/hae.12078
- By:
- Publication type:
- Article
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
- Published in:
- Haemophilia, 2013, v. 19, n. 1, p. 76, doi. 10.1111/j.1365-2516.2012.02916.x
- By:
- Publication type:
- Article
The World Federation of Hemophilia guideline on management of haemophilia.
- Published in:
- Haemophilia, 2013, v. 19, n. 1, p. 1, doi. 10.1111/hae.12074
- By:
- Publication type:
- Article
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis.
- Published in:
- Haemophilia, 2012, v. 18, n. 6, p. 881, doi. 10.1111/j.1365-2516.2012.02897.x
- By:
- Publication type:
- Article
Malignant disease in the haemophilic population: moving towards a management consensus?
- Published in:
- Haemophilia, 2012, v. 18, n. 5, p. 664, doi. 10.1111/j.1365-2516.2012.02846.x
- By:
- Publication type:
- Article
How I treat inhibitors in haemophilia.
- Published in:
- Haemophilia, 2012, v. 18, p. 48, doi. 10.1111/j.1365-2516.2012.02829.x
- By:
- Publication type:
- Article
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.
- Published in:
- Haemophilia, 2012, v. 18, n. 4, p. 503, doi. 10.1111/j.1365-2516.2011.02685.x
- By:
- Publication type:
- Article
Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.
- Published in:
- Haemophilia, 2012, v. 18, n. 4, p. 598, doi. 10.1111/j.1365-2516.2011.02720.x
- By:
- Publication type:
- Article
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. e173, doi. 10.1111/j.1365-2516.2012.02758.x
- By:
- Publication type:
- Article
Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. e164, doi. 10.1111/j.1365-2516.2011.02745.x
- By:
- Publication type:
- Article